Halozyme Therapeutics
HALO
#2398
Rank
NZ$10.76 B
Marketcap
$84.57
Share price
1.19%
Change (1 day)
35.36%
Change (1 year)

Halozyme Therapeutics (HALO) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : NZ$2.89 Billion

According to Halozyme Therapeutics's latest financial reports the company's total liabilities are NZ$2.89 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Halozyme Therapeutics - Total liabilities on balance sheet (from 2002 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31NZ$2.60 B-0.94%
2022-12-31NZ$2.63 B98.18%
2021-12-31NZ$1.32 B123.52%
2020-12-31NZ$0.59 B-15.57%
2019-12-31NZ$0.70 B146.76%
2018-12-31NZ$0.28 B-34.97%
2017-12-31NZ$0.43 B3.37%
2016-12-31NZ$0.42 B109.3%
2015-12-31NZ$0.20 B27.49%
2014-12-31NZ$0.15 B7.33%
2013-12-31NZ$0.14 B41.97%
2012-12-31NZ$0.10 B48.51%
2011-12-31NZ$70.29 M-23.62%
2010-12-31NZ$92.02 M-4.85%
2009-12-31NZ$96.71 M-8.27%
2008-12-31NZ$0.10 B76.74%
2007-12-31NZ$59.65 M82.64%
2006-12-31NZ$32.66 M869.2%
2005-12-31NZ$3.36 M52.25%
2004-12-31NZ$2.21 M426.21%
2003-12-31NZ$0.42 M-63.92%
2002-12-31NZ$1.16 M14619.16%
2001-12-31NZ$0 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
NZ$1.17 B-59.52%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$106.65 B 3,580.12%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$32.60 B 1,024.94%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$220.86 B 7,521.19%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$105.88 B 3,553.55%๐Ÿ‡ซ๐Ÿ‡ท France
NZ$188.16 B 6,392.95%๐Ÿ‡บ๐Ÿ‡ธ USA